Results 201 to 210 of about 18,497,895 (269)

Revising NHE-1: From Cardiac Homeostasis to Heart Failure and Future Drug Development. [PDF]

Cell Biochem Funct
Bouratzis V, Douskou N, Tzavellas NP, Simos YV, Bozidis P, Tsamis KI, Markopoulos GS, Peschos D, Lakkas L.   +8 more
europepmc   +1 more source

Analysing the significance of small conformational changes and low occupancy states in serial crystallographic data

FEBS Open Bio, EarlyView.
This protocol paper outlines methods to establish the success of a time‐resolved serial crystallographic experiment, by means of statistical analysis of timepoint data in reciprocal space and models in real space. We show how to amplify the signal from excited states to visualise structural changes in successful experiments.
Jake Hill, Yelyzaveta Pulnova, Elke De Zitter, Helen M. Ginn, Briony A. Yorke   +4 more
wiley   +1 more source

In vitro and in vivo models for androgenetic alopecia drug development. [PDF]

Dis Model Mech
Tu S, Nanmo A, Migita Y, Asaba T, Seo J, Hamano S, Kageyama T, Fukuda J.   +7 more
europepmc   +1 more source

Optimizing photoactivation of PA‐mCherry for optical pooled CRISPR screens

FEBS Open Bio, EarlyView.
Photoactivatable PA‐mCherry finds widespread use to optically tag individual cells. However, confocal 405 nm UV laser‐scanning (normal scan) is much less efficient than widefield UV illumination, limiting the use of PA‐mCherry on confocal instruments. We remedy this limitation by reporting that rapid and repeated confocal scanning with a low‐intensity,
Sravasti Mukherjee, Giulia Zanetti, Bram van den Broek, Kees Jalink   +3 more
wiley   +1 more source

Optimizing Oligonucleotide Therapeutics: A Model-Informed Drug Development Perspective. [PDF]

Clin Transl Sci
Yuan Y, Sharma V, Bhattaram VA, Pan X, Earp J, Wang Y, Liu J, Zhu H.   +7 more
europepmc   +1 more source

One size does not fit all: An in vitro evaluation of the effects of bezafibrate and medroxyprogesterone acetate on human SH‐SY5Y and U‐87 MG cancer cells

FEBS Open Bio, EarlyView.
Drugs previously repurposed to target blood cancers reduced neuroblastoma and glioblastoma cell growth and viability. However, their levels of anticancer activity were different and their clinical application may be problematic due to side effects at effective doses.
Abhishek Kharawatkar, Francesco Michelangeli, Farhat Latif Khanim, Christopher Martin Bunce, William Eustace Basil Johnson   +4 more
wiley   +1 more source

Fundamentals and emerging frontiers in p53-targeted drug development. [PDF]

Biochem Biophys Rep
Long HD, Zhang N, Wang WE, Ma YS, Liu FX, Chen ZY, Lu CN, Wang XF, Han N, Cai YF, Yang C, Tang XM, Yu H, Jiang H, Fu D, Chu KJ, Wu WG.   +16 more
europepmc   +1 more source

Lipopolysaccharide uptake is augmented in lipopolysaccharide‐tolerant mouse macrophage‐like cells via increased CD14 expression

FEBS Open Bio, EarlyView.
In normal (nontolerant) cells, CD14 is crucial for both LPS uptake and LPS signaling. In LPS‐tolerant cells, in which LPS‐induced TNF‐α and IFN‐β production is suppressed, there is a dramatic increase in surface CD14 expression. The overexpressed CD14 in LPS‐tolerant cells is responsible for the enhanced LPS uptake without inducing pro‐inflammatory ...
Saeka Nishihara, Takayuki Manabe, Mika Jouta, Kiyoshi Kawasaki   +3 more
wiley   +1 more source

Recommendations for the use of clinical outcome assessments in rare disease drug development. [PDF]

EClinicalMedicine
Aiyegbusi OL, McCorry NK, Calvert MJ, Peipert JD, Rivera SC, Muni-Lofra R, Alexis S, Awan F, Bailey T, Billingham L, Callaghan R, Collins C, Currie BM, Dixon M, Duddridge M, Ennis J, Fred L, Greenwell S, Griffiths C, Hareendran A, Illoh OA, Leeson-Beevers K, Letchemanan K, Lister SP, McCabe C, McFatrich M, McKnight AJ, McLaughlin F, Moldovan R, Murray LT, O'Connor DJ, Oko-Osi H, Oni L, Pritchard KM, Rantell KR, Straub V, Barrett TG, LifeArc Accelerating Rare Disease Trials (ARDT) centreaf, LifeArc Accelerating Rare Disease Trials (ARDT) centre.   +38 more
europepmc   +1 more source

Versatile vector tools for efficient protein screening across multiple expression systems

FEBS Open Bio, EarlyView.
A unified vector toolkit enables rapid protein expression screening across E. coli, insect, and mammalian cells. A single primer pair amplifies the target gene, which is inserted into any vector via a standardized interface. This streamlined workflow eliminates repeated cloning steps, accelerating the identification of optimal expression conditions for
Zhimin Zhu, Yaqing Liu, Lei Qin, Feng Yu, Qisheng Wang, Yahui Liu   +5 more
wiley   +1 more source